icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Illinois Bank Shutting Out Cannabis Clients Over Sessions’ Stance

Larry Mishkin, Hoban Law Group, Litigation Practice Group Counsel The Bank of Springfield (Illinois) has notified its existing cannabis-related clients that their money is no good there anymore. Citing what it terms a “legal gray zone” cast by U.S. Attorney General Jeff Sessions, the bank announced in an April 2 letter to customers that all […]
Read more

Something to Declare: Legalized Cannabis Leads to Fewer Border Interceptions

By J.J. McCoy, Senior Managing Editor for New Frontier Data Nationally, reported interceptions of cannabis by the U.S. Customs and Border Protection have been falling dramatically throughout recent years, from 2.53 million pounds in 2011, to 861,231 pounds in 2017 -- a 66% decrease. That dramatic decline mirrors the increase in domestic cannabis production as more […]
Read more

Suddenly, A Season for Industrial Hemp to Spring Forward

By J.J. McCoy, Senior Managing Editor for New Frontier Data Last year, cannabis-industry attorney Bob Hoban told us how he saw “the hemp industry taking huge, huge, huge steps forward. I’ve always seen and still maintain that the hemp industry is going to dwarf the marijuana industry by a long, long, long shot. The hemp industry worldwide […]
Read more

WHO Research About CBDs: They Are A-OK

By J.J. McCoy, Senior Managing Editor for New Frontier Data What We Have Learned: The World Health Organization (WHO) essentially called out the rationale behind the U.S. federal government’s listing cannabis as a Schedule I controlled substance. Newly published findings from the World Health Organization (WHO) about the medicinal benefits of cannabidiol (CBD) fall in direct […]
Read more

Where Do Things Look to Stand with the Rohrabacher-Blumenauer Amendment?

By J.J. McCoy, Senior Managing Editor for New Frontier Data What We Have Learned: As Congress keeps kicking continuing budget resolutions down the calendar, there remain steps for operators to toward self-protection. In what has become a de facto annual event on Capitol Hill (where a version was first proposed in 2001, finally passed in 2014, […]
Read more

Rohrabacher-Blumenauer: What Are The Stakes – Revisited

By J.J. McCoy, Senior Managing Editor for New Frontier Data In what has become a de facto annual event on Capitol Hill (where a version was first proposed in 2001, finally passed in 2014, and renewed each fiscal year since), the Rohrabacher-Blumenauer amendment was again blowing in the wind for the past week amid all the […]
Read more

WHO to DOJ, re: CBD: It’s All (Medicinally) Good

By J.J. McCoy, Senior Managing Editor for New Frontier Data Newly published findings from the World Health Organization (WHO) about the medicinal benefits of cannabidiol (CBD) fall in direct opposition to the stance of the U.S. federal government’s keeping it listed as a Schedule I controlled substance. Publishing recent findings which directly contradict both the established […]
Read more

Top Performing Sectors that Touch the Plant

Among Business That Touch the Plant, Biotech and Pharma Stocks Lead Cannabis Investment Growth In 2016, investment in cannabis businesses that touched the plant grew 306% year over year. That compares to the 161% growth seen in the ancillary market (i.e. businesses that do not touch the plant). Investment in cannabis biotech and pharma companies […]
Read more

Proposed Federal Excise Tax Could Squeeze Legal Cannabis Sales

Proposed Federal Excise Tax Could Squeeze Legal Cannabis Sales In March, H.R.1823 - Marijuana Revenue and Regulation Act was introduced in the House of Representatives by Rep. Carlos Curbelo (R-FL) and Rep. Earl Blumenauer (D-OR) and in the Senate by Sen. Ron Wyden (D-OR), Sen. Rand Paul (R-KY), and Sen. Michael Bennet (D-CO). The bill, […]
Read more

A Month Before 4/20, the 411 on Legislative Efforts

By J.J. McCoy, Senior Managing Editor for New Frontier Data After a week in which U.S. Attorney General Jeff Sessions acknowledged the validity of the Cole memo, it seems a worthwhile time to review where things stand on the national policy front. On three occasions last week, Sessions expressed his personal opposition to legalization, and even his […]
Read more